spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Neurocrine Biosciences 

 HSMN NewsFeed - 13 Oct 2021
Poseida Therapeutics Announces Leadership Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Apr 2020
Neurocrine Biosciences Announces FDA Approval of Once-Daily ONGENTYS(R) (opicapone) as an Add-On Treatment for Patients with Parkinson's Disease Experiencing "Off" Episodes
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 5 Aug 2019
AbbVie Submits New Drug Application to US FDA for Investigational Elagolix for Management of Heavy Menstrual Bleeding Associated with Uterine Fibroids in Women
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Jul 2018
AbbVie Receives U.S. FDA Approval of ORILISSA(TM) (elagolix) for the Management of Moderate to Severe Pain Associated with Endometriosis
Biopharmaceuticals FDA Product Launch
 HSMN NewsFeed - 27 Oct 2017
AbbVie Receives U.S. FDA Priority Review for Investigational Oral Treatment Elagolix for the Management of Endometriosis with Associated Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 5 Oct 2017
Neurocrine Announces FDA Approval of 80 mg INGREZZA(R) (valbenazine) Capsules for the Treatment of Adults with Tardive Dyskinesia (TD)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 6 Sep 2017
AbbVie Submits New Drug Application to U.S. FDA for Investigational Oral Treatment Elagolix for the Management of Endometriosis with Associated Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Apr 2017
Neurocrine Announces INGREZZA(TM) Long-Term Safety and Efficacy Data to be Presented at the 2017 American Academy of Neurology Annual Meeting
Biopharmaceuticals Neurology
 HSMN NewsFeed - 17 Apr 2017
Xencor Appoints Kevin Gorman, Ph.D., to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Jan 2017
Neuropore Therapies Announces Appointment of Dr. Errol De Souza as President and Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 30 Nov 2016
Neurocrine Announces FDA Advisory Committee Meeting to Review INGREZZA(TM) (valbenazine) New Drug Application for the Treatment of Tardive Dyskinesia
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 11 Oct 2016
Neurocrine Announces INGREZZA(TM) (valbenazine) New Drug Application for the Treatment of Tardive Dyskinesia has been Accepted for Priority Review by U.S. FDA
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 3 May 2016
Patara Pharma Appoints Biotechnology Industry Leader John Schmid to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Apr 2016
Symic Appoints Kathleen Gogas, Ph.D., as VP of Preclinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Feb 2016
Neurocrine Announces Initiation of Phase II Clinical Study of VMAT2 Inhibitor Valbenazine in Children and Adolescents with Tourette Syndrome
Biopharmaceuticals Neurology
 HSMN NewsFeed - 7 Dec 2015
Ignyta Appoints William Mccarthy as Chief Business Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Sep 2013
BioMarin Appoints Richard Ranieri as Senior Vice President, Human Resources and Corporate Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jun 2012
Abbott Announces Initiation of Phase 3 Study of Elagolix in Patients with Endometriosis
Biopharmaceuticals
 HSMN NewsFeed - 29 Apr 2011
NeurogesX CEO Anthony DiTonno to Retire by Year End
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Mar 2011
KaloBios Announces Two Significant Additions to Its Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Feb 2011
Cytokinetics Announces Changes to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jun 2010
Abbott and Neurocrine Announce Global Agreement to Develop and Commercialize Elagolix for the Treatment of Endometriosis
Biopharmaceuticals
 HSMN NewsFeed - 15 Apr 2010
Dendreon Appoints Richard Ranieri as Senior Vice President of Human Resources
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Mar 2010
Biodel Announces Senior Leadership Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Nov 2009
Receptos Completes $25M Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 9 Jul 2009
Poniard Pharmaceuticals Appoints Gary A. Lyons to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 May 2009
Neurocrine Announces Work Force Restructuring
Biopharmaceuticals
 HSMN NewsFeed - 30 Mar 2009
BrainCells Inc. Appoints Philip Jochelson, M.D. Chief Medical Officer and Jason Levin Chief Business Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 20 Jan 2009
NovaBay (NBY) Appoints Harry F. Hixson, Jr., PhD, Former Amgen President/Chief Operating Officer to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Mar 2008
OREXIGEN(TM) Therapeutics Appoints Carol Baum as Vice President of Commercialization
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jan 2008
Neurocrine Announces Appointment of Kevin Gorman, Ph.D., as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jan 2008
Joseph A. Mollica Named Chairman of Celator(R) Pharmaceuticals Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Dec 2007
Neurocrine Announces Work Force Restructuring
Biopharmaceuticals
 HSMN NewsFeed - 13 Dec 2007
Neurocrine Receives Approvable Letter for Indiplon Capsules with Additional Safety and Efficacy Data Required by FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Jun 2007
Neurocrine Announces Resubmission of New Drug Application for Indiplon Capsules
Biopharmaceuticals
 HSMN NewsFeed - 6 Jun 2007
CoMentis Announces Appointment of Martin Tolar, M.D., Ph.D., as Vice President of Strategic and Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Feb 2007
Neurocrine Biosciences Announces the Resignation of Adrian Adams From the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Feb 2007
Sequenom Names Financial Veteran Paul W. Hawran Chief Financial Officer
Diagnostics Personnel
 HSMN NewsFeed - 22 Jan 2007
Neurocrine Announces Plans to Resubmit NDA for Indiplon Capsules in Q2 2007
Biopharmaceuticals
 HSMN NewsFeed - 8 Jan 2007
Ambit Biosciences Appoints Wendell Wierenga, Ph.D., as Executive Vice President of Research & Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jan 2007
Neurocrine Biosciences Announces Positive Results From Second Phase II Study With Its Orally Active GnRH Receptor Antagonist in Endometriosis
Biopharmaceuticals
 HSMN NewsFeed - 21 Dec 2006
Neurocrine Announces Organizational Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Sep 2006
Neurocrine Announces Organizational Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Sep 2006
Neurocrine Reports Results of FDA End-of-Review Meeting on Indiplon Capsules NDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Aug 2006
Paul W. Hawran Named to Sequenom Board of Directors
Diagnostics Personnel
 HSMN NewsFeed - 7 Aug 2006
Neurocrine Announces San Diego Campus Restructuring
Biopharmaceuticals
 HSMN NewsFeed - 26 Jul 2006
Neurocrine Announces the Release of the Sales Force
Biopharmaceuticals
 HSMN NewsFeed - 26 Jul 2006
Halozyme Therapeutics Names Robert Little Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jun 2006
Neurocrine and Pfizer Terminate Collaboration Agreement for Indiplon
Biopharmaceuticals
 HSMN NewsFeed - 15 Jun 2006
Neurocrine Completes Review of Indiplon Action Letters
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 May 2006
Neurocrine Receives Approvable Letter for indiplon Capsules and Non-Approvable for indiplon Tablets for the Treatment of Insomnia
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Mar 2006
Neurocrine Biosciences Announces Results of The Phase II Study in Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 10 Jan 2006
Neurocrine Provides Update of Food and Drug Administration's Review of Indiplon
Biopharmaceuticals FDA
Return to NewsFeed  

 Additional items found! 31

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 31 additional stories matching:
Neurocrine Biosciences
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.